ConductScience.org, home

Paper8043223

Novel oral drug formulations. Their potential in modulating adverse effects.

Florence AT and 1 other. Drug Saf, 1994. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Novel oral drug formulations. Their potential in modulating adverse effects. Papers, record 8043223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8043223

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel oral drug formulations. Their potential in modulating adverse effects.
PubMed
Journal
Drug Saf
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Florence ATA T
2Jani PUP U

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Cardiovascular AgentsMajor topic
Delayed-Action PreparationsMajor topic
Drug Delivery SystemsMajor topic
Administration, Oral
Dosage Forms
Food
Gastrointestinal Diseases
Gastrointestinal Transit
Humans
Intestinal Absorption
Safety

Source PubMed

Download CSV of topics

References215

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1868891Absolute bioavailability of oral theophylline.Am J Hosp Pharm1977https://conductscience.org/library/papers/868891PubMed
26136612A polymeric drug for treatment of inflammatory bowel disease.J Med Chem1983https://conductscience.org/library/papers/6136612PubMed
33732895Transit of pharmaceutical dosage forms through the small intestine.Gut1986https://conductscience.org/library/papers/3732895PubMed
41950962Drug-nutrient interactions.Am Fam Physician1991https://conductscience.org/library/papers/1950962PubMed
51799930Chronopharmacokinetics and cardiovascular effects of nifedipine.Chronobiol Int1991https://conductscience.org/library/papers/1799930PubMed
62717518Hollow fibers as an oral sustained-release delivery system.Pharm Res1989https://conductscience.org/library/papers/2717518PubMed
72342687Overdose of sustained release verapamil.N Z Med J1990https://conductscience.org/library/papers/2342687PubMed
82684551Ketotifen in the prophylaxis of extrinsic bronchial asthma. A multicenter controlled double-blind study with a modified-release formulation.Chest1989https://conductscience.org/library/papers/2684551PubMed
92512655A comparative study of standard and slow-release oral lithium carbonate products.S Afr Med J1989https://conductscience.org/library/papers/2512655PubMed
103190808Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.Arzneimittelforschung1988https://conductscience.org/library/papers/3190808PubMed
111796748Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.Gynecol Endocrinol1991https://conductscience.org/library/papers/1796748PubMed
127338583Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study.J Dermatol Surg Oncol1981https://conductscience.org/library/papers/7338583PubMed
133236215Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.J Pharmacobiodyn1988https://conductscience.org/library/papers/3236215PubMed
1431431Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets.J Pharm Pharmacol1978https://conductscience.org/library/papers/31431PubMed
151712708Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.Drugs1991https://conductscience.org/library/papers/1712708PubMed
162767329Sustained-release verapamil as a first-step drug in the treatment of mild to moderate hypertension.J Int Med Res1989https://conductscience.org/library/papers/2767329PubMed
177126413An oral preparation to release drugs in the human colon.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7126413PubMed
183301301Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia.Drugs1987https://conductscience.org/library/papers/3301301PubMed
197042294Rate-controlled drug dosage.Drugs1982https://conductscience.org/library/papers/7042294PubMed
203622317The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.Drugs1987https://conductscience.org/library/papers/3622317PubMed

See all 215 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
39330195Antibiotic-Loaded Dendrimer Hydrogels in Periodontal Bone Regeneration: An In Vitro Release Feasibility Study.Gels2024https://conductscience.org/library/papers/39330195PubMed
38808156Oral administration microrobots for drug delivery.Bioact Mater2024https://conductscience.org/library/papers/38808156PubMed
38004612Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges.Pharmaceutics2023https://conductscience.org/library/papers/38004612PubMed
37238978Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes.Biomedicines2023https://conductscience.org/library/papers/37238978PubMed
37196080Breakthrough treatments for accelerated wound healing.Sci Adv2023https://conductscience.org/library/papers/37196080PubMed
36354614Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents: Recent Advances.Gels2022https://conductscience.org/library/papers/36354614PubMed
36297555Pulsed Laser Photo-Crosslinking of Gelatin Methacryloyl Hydrogels for the Controlled Delivery of Chlorpromazine to Combat Antimicrobial Resistance.Pharmaceutics2022https://conductscience.org/library/papers/36297555PubMed
36070365Advances toward transformative therapies for tendon diseases.Sci Transl Med2022https://conductscience.org/library/papers/36070365PubMed
35350319Hydrogel-Mediated Release of TRPV1 Modulators to Fine Tune Osteoclastogenesis.ACS Omega2022https://conductscience.org/library/papers/35350319PubMed
33782151Combination Adjuvants Affect the Magnitude of Effector-Like Memory CD8 T Cells and Protection against Listeriosis.Infect Immun2021https://conductscience.org/library/papers/33782151PubMed
33507525Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.CNS Drugs2021https://conductscience.org/library/papers/33507525PubMed
32734721Biomaterial Based Strategies for Engineering New Lymphatic Vasculature.Adv Healthc Mater2020https://conductscience.org/library/papers/32734721PubMed
30908806Biomaterials to Mimic and Heal Connective Tissues.Adv Mater2019https://conductscience.org/library/papers/30908806PubMed
29657852Designing hydrogels for controlled drug delivery.Nat Rev Mater2016https://conductscience.org/library/papers/29657852PubMed
25289142Therapeutic drug monitoring in a developing nation: a clinical guide.JRSM Open2014https://conductscience.org/library/papers/25289142PubMed
22915856Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.Int J Nanomedicine2012https://conductscience.org/library/papers/22915856PubMed
15456329Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.Drugs2004https://conductscience.org/library/papers/15456329PubMed
12408733Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.Drug Saf2002https://conductscience.org/library/papers/12408733PubMed
11600467Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.Gut2001https://conductscience.org/library/papers/11600467PubMed
11510630Pegylation: a novel process for modifying pharmacokinetics.Clin Pharmacokinet2001https://conductscience.org/library/papers/11510630PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8043223

GET https://conductscience.org/api/papers/v1/8043223/references?page=2